These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8609150)

  • 1. Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-type-specific and dose-dependent.
    Stein U; Walther W; Shoemaker RH
    J Cancer Res Clin Oncol; 1996; 122(5):275-82. PubMed ID: 8609150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the human MDR1 promoter for heat-inducible expression of therapeutic genes.
    Walther W; Stein U; Schlag PM
    Int J Cancer; 2002 Mar; 98(2):291-6. PubMed ID: 11857422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.
    Stein U; Walther W; Wunderlich V
    Eur J Cancer; 1994; 30A(10):1541-5. PubMed ID: 7833115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells.
    Kohno K; Tanimura H; Sato S; Nakayama Y; Makino Y; Wada M; Fojo AT; Kuwano M
    J Biol Chem; 1994 Aug; 269(32):20503-8. PubMed ID: 7914196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of MDR antagonists on the cidal activity of vincristine for cells expressing MDR-1 is superior to those expressing MRP.
    Hosoi E; Hirose M; Hamano S; Morimoto M; Kuroda Y
    Int J Oncol; 1998 Aug; 13(2):343-8. PubMed ID: 9664131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta.
    Gill PK; Gescher A; Gant TW
    Eur J Biochem; 2001 Aug; 268(15):4151-7. PubMed ID: 11488907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.
    Rumjanek VM; Trindade GS; Wagner-Souza K; de-Oliveira MC; Marques-Santos LF; Maia RC; Capella MA
    An Acad Bras Cienc; 2001 Mar; 73(1):57-69. PubMed ID: 11246270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.
    Kohno K; Sato S; Takano H; Matsuo K; Kuwano M
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1415-21. PubMed ID: 2575381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
    Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
    Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance.
    Barancík M; Bohácová V; Kvackajová J; Hudecová S; Krizanová O; Breier A
    Eur J Pharm Sci; 2001 Aug; 14(1):29-36. PubMed ID: 11457647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells.
    Morrow CS; Nakagawa M; Goldsmith ME; Madden MJ; Cowan KH
    J Biol Chem; 1994 Apr; 269(14):10739-46. PubMed ID: 7908296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress.
    Miyazaki M; Kohno K; Uchiumi T; Tanimura H; Matsuo K; Nasu M; Kuwano M
    Biochem Biophys Res Commun; 1992 Sep; 187(2):677-84. PubMed ID: 1356336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
    Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium.
    Takakura Y; Hinoi T; Oue N; Sasada T; Kawaguchi Y; Okajima M; Akyol A; Fearon ER; Yasui W; Ohdan H
    Cancer Res; 2010 Sep; 70(17):6767-78. PubMed ID: 20699370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.